aster.cloud aster.cloud
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
    • Learning
  • Tools
  • About
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
    • Learning
  • Tools
  • About
aster.cloud aster.cloud
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
    • Learning
  • Tools
  • About
Medicine
  • People
  • Technology

Drug Resistance: Could Global Goals Be The Answer To This Worldwide Health Crisis?

  • aster.cloud
  • January 19, 2024
  • 2 minute read
  • This year will be critical in combatting the global health threat of drug-resistant infections.
  • Drug resistance has dropped off the global agenda, and commitments and reports have had limited impact so far.
  • Tangible targets and accountability are needed to drive progress and prevent losing the advances of modern medicine.

When thinking about the top 10 global public health threats, your first thoughts might include viruses with pandemic potential, climate change, or poverty. Drug-resistant infections might not immediately jump to mind.

But drug-resistant infections, caused by antimicrobial resistance (AMR), are a huge global issue. Research published in The Lancet in 2022, unveiled the very real human cost of this crisis – causing 1.27 million deaths in 2019 alone, and associated with an additional 3.7 million deaths (which is more than deaths caused by HIV/AIDs and malaria combined).


Partner with aster.cloud
for your next big idea.
Let us know here.



From our partners:

CITI.IO :: Business. Institutions. Society. Global Political Economy.
CYBERPOGO.COM :: For the Arts, Sciences, and Technology.
DADAHACKS.COM :: Parenting For The Rest Of Us.
ZEDISTA.COM :: Entertainment. Sports. Culture. Escape.
TAKUMAKU.COM :: For The Hearth And Home.
ASTER.CLOUD :: From The Cloud And Beyond.
LIWAIWAI.COM :: Intelligence, Inside and Outside.
GLOBALCLOUDPLATFORMS.COM :: For The World's Computing Needs.
FIREGULAMAN.COM :: For The Fire In The Belly Of The Coder.
ASTERCASTER.COM :: Supra Astra. Beyond The Stars.
BARTDAY.COM :: Prosperity For Everyone.

This is not a new crisis, but it is one that requires urgent action to avoid a world where a common medical procedure poses a high risk of infection and lengthy hospital stays, with fewer, if any, effective treatments for drug-resistant infections.

What action has been taken to combat drug resistance?

This year marks a decade since the beginning of the landmark Review on Antimicrobial Resistance led by economist Lord Jim O’Neill, which provided the bigger picture of the scale of the problem, elevating this global health threat up the global agenda and offering solutions for governments and industries to prevent it from growing.

In the 10 years since the review there have been a raft of global reports and political commitments, including the World Health Organization’s (WHO) global action plan on AMR, a High Level Meeting on AMR at the UN General Assembly in 2016, and the 2022 Muscat Ministerial Manifesto on AMR. But these have delivered limited impacts, and we have seen little concrete action to address this issue.

Read More  Apple Unveils M2, Taking The Breakthrough Performance And Capabilities Of M1 Even Further

For too long drug resistance has not been seen as a high priority for decision makers, despite the risk it poses to modern medicine and potential cost to economies. And on the rare occasion it does feature on the global agenda, the spotlight is focused on building capacity and understanding. While both are essential, we are still missing ways to measure progress, setting evidence-based goals and ensuring action is taken to fill the gaps so global efforts are kept on track.

Establishing bold clear targets – like the 1.5C target for climate change – is the key to incentivise and galvanise support for action against drug resistance. With achievable but ambitious targets and mechanisms to track progress against them, we can drive progress through global collaboration to develop new novel antibiotics and engage with communities most affected in low-and middle-income countries.

By: Jeremy Knox (Head of Policy for Infectious Disease, Wellcome) and Steffen Pierini Lüders (Senior Vice-President, Corporate Affairs, Novo Nordisk Foundation)
Originally published at: World Economic Forum


For enquiries, product placements, sponsorships, and collaborations, connect with us at [email protected]. We'd love to hear from you!

Our humans need coffee too! Your support is highly appreciated, thank you!

aster.cloud

Related Topics
  • Davos Agenda
  • Drug resistance
  • Global health
  • Health
  • Healthcare
  • Medicine
You May Also Like
View Post
  • Computing
  • Multi-Cloud
  • Technology

Enterprises are keen on cloud repatriation – but not for all workloads

  • June 4, 2025
View Post
  • Computing
  • Multi-Cloud
  • Technology

Reliance on US tech providers is making IT leaders skittish

  • May 28, 2025
View Post
  • Computing
  • Multi-Cloud
  • Technology

Examine the 4 types of edge computing, with examples

  • May 28, 2025
View Post
  • Computing
  • Multi-Cloud
  • Technology

AI and private cloud: 2 lessons from Dell Tech World 2025

  • May 28, 2025
View Post
  • Computing
  • Multi-Cloud
  • Technology

TD Synnex named as UK distributor for Cohesity

  • May 28, 2025
View Post
  • Computing
  • Multi-Cloud
  • Technology

Broadcom’s ‘harsh’ VMware contracts are costing customers up to 1,500% more

  • May 28, 2025
View Post
  • Computing
  • Multi-Cloud
  • Technology

Weigh these 6 enterprise advantages of storage as a service

  • May 28, 2025
View Post
  • Computing
  • Multi-Cloud
  • Technology

Pulsant targets partner diversity with new IaaS solution

  • May 23, 2025

Stay Connected!
LATEST
  • 1
    Enterprises are keen on cloud repatriation – but not for all workloads
    • June 4, 2025
  • 2
    The Summer Adventures : Hiking and Nature Walks Essentials
    • June 2, 2025
  • 3
    Just make it scale: An Aurora DSQL story
    • May 29, 2025
  • 4
    Reliance on US tech providers is making IT leaders skittish
    • May 28, 2025
  • Examine the 4 types of edge computing, with examples
    • May 28, 2025
  • AI and private cloud: 2 lessons from Dell Tech World 2025
    • May 28, 2025
  • 7
    TD Synnex named as UK distributor for Cohesity
    • May 28, 2025
  • Weigh these 6 enterprise advantages of storage as a service
    • May 28, 2025
  • 9
    Broadcom’s ‘harsh’ VMware contracts are costing customers up to 1,500% more
    • May 28, 2025
  • 10
    Pulsant targets partner diversity with new IaaS solution
    • May 23, 2025
about
Hello World!

We are aster.cloud. We’re created by programmers for programmers.

Our site aims to provide guides, programming tips, reviews, and interesting materials for tech people and those who want to learn in general.

We would like to hear from you.

If you have any feedback, enquiries, or sponsorship request, kindly reach out to us at:

[email protected]
Most Popular
  • Understand how Windows Server 2025 PAYG licensing works
    • May 20, 2025
  • By the numbers: How upskilling fills the IT skills gap
    • May 21, 2025
  • 3
    Cloud adoption isn’t all it’s cut out to be as enterprises report growing dissatisfaction
    • May 15, 2025
  • 4
    Hybrid cloud is complicated – Red Hat’s new AI assistant wants to solve that
    • May 20, 2025
  • 5
    Google is getting serious on cloud sovereignty
    • May 22, 2025
  • /
  • Technology
  • Tools
  • About
  • Contact Us

Input your search keywords and press Enter.